Massimo Procopio

2.7k total citations
83 papers, 1.9k citations indexed

About

Massimo Procopio is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, Massimo Procopio has authored 83 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Endocrinology, Diabetes and Metabolism, 20 papers in Molecular Biology and 19 papers in Physiology. Recurrent topics in Massimo Procopio's work include Growth Hormone and Insulin-like Growth Factors (42 papers), Pituitary Gland Disorders and Treatments (18 papers) and Metabolism, Diabetes, and Cancer (16 papers). Massimo Procopio is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (42 papers), Pituitary Gland Disorders and Treatments (18 papers) and Metabolism, Diabetes, and Cancer (16 papers). Massimo Procopio collaborates with scholars based in Italy, Belarus and Russia. Massimo Procopio's co-authors include Ezio Ghigo, F. Camanni, Mauro Maccario, Giorgio Borretta, Silvia Grottoli, Emanuela Arvat, Enrico Mazza, S. E. Oleandri, J. Bellone and Massimo Terzolo and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, The American Journal of Cardiology and International Journal of Obesity.

In The Last Decade

Massimo Procopio

83 papers receiving 1.9k citations

Peers

Countries citing papers authored by Massimo Procopio

Since Specialization

Citations

This map shows the geographic impact of Massimo Procopio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Procopio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Procopio more than expected).

Fields of papers citing papers by Massimo Procopio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Procopio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Procopio. The network helps show where Massimo Procopio may publish in the future.

Co-authorship network of co-authors of Massimo Procopio

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Procopio. A scholar is included among the top collaborators of Massimo Procopio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Procopio. Massimo Procopio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mild Hyponatremia Is Not Associated With Degradation of Trabecular Bone Microarchitecture Despite Bone Mass Loss 2024 ·The Journal of Clinical Endocrinology & Metabolism ·Fabio Bioletto, (unknown), Alessandro Maria Berton, Nunzia Prencipe, (unknown), (unknown), (unknown), (unknown), Valentina Gasco, Silvia Grottoli, Ezio Ghigo, Emanuela Arvat, Massimo Procopio, (unknown)	5
2	Mild hyponatremia is not associated with degradation of trabecular bone microarchitecture despite bone mass loss 2024 ·Endocrine Abstracts ·Fabio Bioletto, (unknown), Alessandro Maria Berton, Nunzia Prencipe, (unknown), (unknown), (unknown), (unknown), Valentina Gasco, Silvia Grottoli, Ezio Ghigo, Emanuela Arvat, Massimo Procopio, (unknown)	1
3	Fracture risk assessment in an Italian group of transgender women after gender-confirming surgery 2020 ·Journal of Bone and Mineral Metabolism ·Giovanna Motta, (unknown), (unknown), Paolo Riccardo Brustio, Chiara Manieri, Ezio Ghigo, Massimo Procopio, Fabio Lanfranco	13
4	Effect of 1-year oral cholecalciferol on a metabolic profile and blood pressure in poor-controlled type 2 diabetes mellitus: an open-label randomized controlled pilot study 2020 ·Journal of Endocrinological Investigation ·(unknown), (unknown), Ezio Ghigo, Massimo Procopio	6
5	Il Trattamento tributario dei costi relativi al sostegno delle società benefit 2017 ·Massimo Procopio	3
6	Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial 2017 ·Acta Diabetologica ·Simona Bo, Valentina Ponzo, Andrea Evangelista, Giovannino Ciccone, Ilaria Goitre, Francesca Saba, Massimo Procopio, Maurizio Cassader, Roberto Gambino	22
7	Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial 2016 ·Pharmacological Research ·Simona Bo, Valentina Ponzo, Giovannino Ciccone, Andrea Evangelista, Francesca Saba, Ilaria Goitre, Massimo Procopio, G. F. Pagano, M. Cassader, (unknown)	126
8	The reduction of bone mineral density in postmenopausal women with primary hyperparathyroidism is higher in the presence of concomitant GH secretion impairment 2006 ·European Journal of Endocrinology ·Elisabetta Cecconi, Maurizio Gasperi, M. Genovesi, Fausto Bogazzi, L. Grasso, Filomena Cetani, Massimo Procopio, Claudio Marcocci, Luigi Bartalena, Enio Martino	2
9	Comparison of frequency of insulin resistance after coronary stenting in patients with type 2 diabetes mellitus with versus without coronary restenosis 2004 ·The American Journal of Cardiology ·Mauro Feola, Flavio Ribichini, Valeria Ferrero, Massimo Procopio, (unknown), Antonello Vado, Giorgio Borretta, Giacomo Boccuzzi, Corrado Vassanelli, E Uslenghi	4
10	Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients 1999 ·International Journal of Obesity ·Mauro Maccario, J. Ramunni, (unknown), Massimo Procopio, Silvia Grottoli, Ruth Rossetto, (unknown), Gianluca Aimaretti, F. Camanni, Ezio Ghigo	75
11	Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity 1999 ·Journal of Endocrinological Investigation ·S. E. Oleandri, (unknown), Ruth Rossetto, Massimo Procopio, Silvia Grottoli, (unknown), Carlotta Gauna, C. Ganzaroli, Ezio Ghigo	25
12	Cholinergic enhancement by pyridostigmine increases the insulin response to glucose load in obese patients but not in normal subjects 1997 ·International Journal of Obesity ·G. Del Rió, Massimo Procopio, Moreno Bondi, P Marrama, Renata Menozzi, (unknown), Silvia Grottoli, Mauro Maccario, A Velardo, Ezio Ghigo	29
13	In Obesity, Glucose Load Loses Its Early Inhibitory, But Maintains Its Late Stimulatory, Effect on Somatotrope Secretion¹ 1997 ·The Journal of Clinical Endocrinology & Metabolism ·Silvia Grottoli, Massimo Procopio, Mauro Maccario, Michele Zini, S. E. Oleandri, F. Tassone, Roberto Valcavi, Ezio Ghigo	14
14	Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesity 1996 ·Journal of Endocrinological Investigation ·Mauro Maccario, Silvia Grottoli, Massimo Procopio, S. E. Oleandri, Alessandro Barberis, E. Ciccarelli, F. Camanni, Ezio Ghigo	2
15	Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity 1996 ·Metabolism ·Mauro Maccario, Massimo Procopio, Silvia Grottoli, S. E. Oleandri, (unknown), (unknown), F. Camanni, Ezio Ghigo	43
16	Short‐term fasting in obesity fails to restore the blunted GH responsiveness to GH‐releasing hormone alone or combined with arginine 1995 ·Clinical Endocrinology ·Massimo Procopio, Mauro Maccario, Silvia Grottoli, S. E. Oleandri, (unknown), F. Camanni, Ezio Ghigo	20
17	Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity 1992 ·Metabolism ·Ezio Ghigo, Massimo Procopio, (unknown), Emanuela Arvat, Francesca Valente, Mauro Maccario, Enrico Mazza, F. Camanni	63
18	Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging 1990 ·European Journal of Endocrinology ·Ezio Ghigo, S. Goffi, Emanuela Arvat, M. Nicolosi, Massimo Procopio, J. Bellone, E. Imperiale, Enrico Mazza, (unknown), F. Camanni	29
19	A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone 1990 ·Journal of Endocrinological Investigation ·Ezio Ghigo, E. Imperiale, (unknown), Enrico Mazza, J. Bellone, Emanuela Arvat, Massimo Procopio, S. Goffi, Antonella Barreca, P. Chiabotto, R. Lala, C. De Sanctis, M. Boghen, (unknown), F. Camanni	21
20	Cholinergic Enhancement by Pyridostigmine Potentiates Spontaneous Diurnal but not Nocturnal Growth Hormone Secretion in Short Children 1989 ·Neuroendocrinology ·Ezio Ghigo, E. Imperiale, Enrico Mazza, S. Goffi, Massimo Procopio, Eugenio E. Müller, F. Camanni	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact